Beyond Metabolic Health: Large-Scale Study Links GLP-1 Medications to Significant Reductions in Mental Health Risks
"The integration of metabolic and mental health treatment enters a new era as semaglutide demonstrates a 42% lower risk of psychiatric decline, suggesting these medications may fundamentally stabilize the brain’s…